Expression of class 3 semaphorins and their receptors in human breast neoplasia

Histopathology

Volumn 59, Issue 2, 2011, Pages 274-282

  Staton, Carolyn A ^a   Shaw, Lucy A ^a   Valluru, Manoj ^a   Hoh, Leslie ^a   Koay, Ivan ^a   Cross, Simon S ^a   Reed, Malcolm W ^a   Brown, Nicola J ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Breast cancer; Class 3 semaphorin; Neuropilin; Plexin; VEGF

Indexed keywords

NEUROPILIN 1; NEUROPILIN 2; PLEXIN; PLEXIN A1; PLEXIN A2; PLEXIN A3; PLEXIN A4; SEMAPHORIN; SEMAPHORIN 3; SEMAPHORIN 3A; SEMAPHORIN 3F; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER INVASION; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIUM CELL; EPITHELIUM CELL; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPERPLASIA; INTRADUCTAL CARCINOMA; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL;

BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; NERVE TISSUE PROTEINS; RECEPTORS, CELL SURFACE; SEMAPHORINS;

EID: 80052227128     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.03922.x     Document Type: Article

References (27)

1. Semaphorin Nomenclature Committee. Unified nomenclature for the semaphorins/collapsins. Cell 1999; 97; 551-552.
2. Neufeld G, Kessler O. The semaphorins: versatile regulators of tumour progression and tumour angiogenesis. Nat. Rev. Cancer 2008; 8; 632-645.
3. Xiang RH, Hensel CH, Garcia DK et al. Isolation of the human semaphorin III/F gene (SEMA3F) at chromosome 3p21, a region deleted in lung cancer. Genomics 1996; 32; 39-48.
4. Sekido Y, Bader S, Latif F et al. Human semaphorins A(V) and IV reside in the 3p21.3 small cell lung cancer deletion region and demonstrate distinct patterns. Proc. Natl Acad. Sci. USA 1996; 93; 4120-4125.
5. Drenberg CD, Livingston S, Chen R, Kruk PA, Nicosia SV. Expression of semaphorin 3F and its receptors in epithelial ovarian cancer, fallopian tubes, and secondary Müllerian tissues. Obstet. Gynecol. Int. 2009; 2009; 730-739.
6. Campioni M, Ambrogi V, Pompeo E et al. Identification of genes down-regulated during lung cancer progression: a cDNA array study. J. Exp. Clin. Cancer Res. 2008; 27; 38.
7. Staton CA, Kumar I, Reed MWR, Brown NJ. Neuropilins in physiological and pathological angiogenesis. J. Pathol. 2007; 212; 237-248.
8. Kessler O, Shraga-Heled N, Lange T et al. Semaphorin 3F is an inhibitor of tumour angiogenesis. Cancer Res. 2008; 64; 1008-1015.
9. Bachelder RE, Lipscomb EA, Lin X et al. Competing autocrin pathways involving alternative neuropilin-1 ligands regulate chemotaxis of carcinoma cells. Cancer Res. 2003; 63; 5230-5233.
10. Wiechmann L, Kuerer HM. The molecular journey from ductal carcinoma in situ to invasive breast cancer. Cancer 2008; 112; 2130-2142.
11. Arpino G, Laucirica R, Elledge RM. Premalignant and in situ breast disease: biology and clinical implications. Ann. Intern. Med. 2005; 143; 446-457.
12. Bluff JE, Menakuru SR, Cross SS et al. Angiogenesis is associated with the onset of hyperplasia in human ductal breast disease. Br. J. Cancer 2009; 101; 666-672.
13. Guttmann-Raviv N, Shraga-Heled N, Varshavsky A, Guimaraes-Sternberg C, Kessler O, Neufeld G. Semaphorin-3A and semaphorin-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis. J. Biol. Chem. 2007; 282; 26294-26305.
14. Osada R, Horiuchi A, Kikuchi N et al. Expression of semaphorins, vascular endothelial growth factor, and their common receptor neuropilins and allelic loss of semaphorin locaus in epithelial ovarian neoplasms: increased ratio of vascular endothelial growth factor to semaphorin is a poor prognostic factor in ovarian carcinomas. Hum. Pathol. 2006; 37; 1414-1425.
15. Joseph D, Ho SM, Syed V. Hormonal regulation and distinct functions of semaphorin-3B and semaphorin-3F in ovarian cancer. Mol. Cancer Ther. 2010; 9; 499-509.
16. Tomizawa Y, Sekido Y, Kondo M et al. Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B. Proc. Natl Acad. Sci. USA 2001; 98; 13954-13959.
17. Barresi V, Vitarelli E, Cerasoli S. Semaphorin3A immunohistochemical expression in human meningiomas: correlation with the microvessel density. Virchows Arch. 2009; 454; 563-571.
18. Pronina IV, Loginov VI, Prasolov VS et al. Alteration of SEMA3B gene expression levels in epithelial tumors. Mol. Biol. (Mosk.) 2009; 43; 439-445.
19. Castro-Rivera E, Ran S, Brekken RA, Minna JD. Semaphorin 3B inhibits the phosphatidylinositol 3-kinase/Akt pathway through neuropilin-1 in lung and breast cancer cells. Cancer Res. 2008; 68; 8295-8303.
20. Soker S, Miao HQ, Nomi M, Takashima S, Klagsbrun M. VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding. J. Cell. Biochem. 2002; 85; 357-368.
21. Hansel DE, Wilentz RE, Yeo CJ, Schulick RD, Montgomery E, Maitra A. Expression of neuropilin-1 in high-grade dysplasia, invasive cancer, and metastases of the human gastrointestinal tract. Am. J. Surg. Pathol. 2004; 28; 347-356.
22. Ochiumi T, Kitadai Y, Tanaka S, Akagi M, Yoshihara M, Chayama K. Neuropilin-1 is involved in regulation of apoptosis and migration of human colon cancer. Int. J. Oncol. 2006; 29; 105-116.
23. Escudero-Esparza A, Martin TA, Douglas-Jones A, Mansel RE, Jiang WG. PGF isoforms, PLGF-1 and PGF-2 and the PGF receptor, neuropilin, in human breast cancer: prognostic significance. Oncol. Rep. 2010; 23; 537-544.
24. Stephenson JM, Banerjee S, Saxena NK, Cherian R, Banerjee SK. Neuropilin-1 is differentially expressed in myoepithelial cells and vascular smooth muscle cells in preneoplastic and neoplastic human breast: a possible marker for the progression of breast cancer. Int. J. Cancer 2002; 101; 409-414.
25. Hall GH, Turnbull LW, Bedford K, Richmond I, Helboe L, Atkin SL. Neuropilin-1 and VEGF correlate with somatostatin expression and microvessel density in ovarian tumours. Int. J. Oncol. 2005; 27; 1283-1288.
26. Yasuoka H, Kodama R, Tsujimoto M et al. Neuropilin-2 expression in breast cancer: correlation with lymph node metastasis, poor prognosis, and regulation of CXCR4 expression. BMC Cancer 2009; 9; 220.
27. Ghosh S, Sullivan CA, Zerkowski MP et al. High levels of vascular endothelial growth factor and its receptors (VEGFR-1, VEGFR-2, neuropilin-1) are associated with worse outcome in breast cancer. Hum. Pathol. 2008; 39; 1835-1843.